

Comment Info: =================

General Comment:Dear Mr. Zeller:

I am writing as an individual consumer to request an extension of the comment period for the Food and Drug Administration's ("FDA") Proposed Rule Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act, as amended by the Family Smoking and Prevention and Tobacco Control Act (the "Proposed Rule") published at 79 Fed. Reg. 23,142 and Federal Register No. 2014-09491. On behalf of myself, and the vaping comunity, I am requesting that the comment period for the Proposed Rule be extended by the FDA for an additional 105 days, from its current 75-day period, to 180 days.The Proposed Rule raises a number of significant issues and questions that are very important and relevant to me, as a consumer of products that are proposed for regulation under the Proposed Rule. The Proposed Rule asks about a hundred different questions I might want to respond to. I want to provide my thoughts, opinions, and comments on many of these issues, but my time to devote to researching and providing thoughtful and intelligent comments on these important questions is limited.
I have already spent many hours researching and breaking down these issues, but they take time. I know that the FDA took many years to even come up with the Proposed Rule, so I do not think it is at all unreasonable to allow the public a mere six months to comment on it, for the sake of a mutually beneficial resolution to the matter at hand. This is our only opportunity, as consumers and comunity members, to provide our feedback and suggestions to the proposed regulation the Food and Drug Administration is offering. 
I feel very strongly about e-cigarettes as an alternative to combustible cigarettes, and an oportunity to creat hundreds of jobs in the United States, as many manufacturers and vendors have already done so. Quite simply, I firmly believe that they saved not only my life but many accross our country and provided many needed jobs as well. I wish to provide you with my personal story, as well as science- and evidence-based responses to your questions so that you can take the communities comments, opinions and concerns, as well as mine, into account. I realize that the FDA has the authority under 21 CFR 10.40 to extend this time frame and that the FDA has exercised this authority on numerous occasions in the past, Hoping you will see the need to do so once more, I would therefore ask that you do so here, so that all stakeholders have the opportunity to provide their comments, and concerns on this proposed regulation.

Thank you for having taken the time to 
read and take this letter into account, 
have a wonderful day.
Sincerely and appreciatively, Hector
From Las Vegas NV.
